<?xml version="1.0" encoding="UTF-8"?>
<p>2. Methods: I recommend stating what the African validation was for TREAT-B. That is that is was development of a scoring system to approximate EASL criteria. It was not validated to identify individuals at higher risk for CHB complications.</p>
